RxDoctor Payments Data

Samuel Waller, MD

Neurological Surgery · Anchorage, AKNPI 1053583211

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Globus Medical accounts for 63.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $11,859 and has fallen 71.1% since, to $3,423 in 2025.

$45,187in general payments, 2019–2025

Across 199 payments — averaging $227.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$29K
  • Medtronic$8K
  • Cerapedics Inc.$6K
  • Zimmer Biomet$1K
  • Si-bone, Inc.$479
  • Nevro Corp.$318
  • plus $787 from 11 others

What the payments were for

  • Consulting fees$18,87542%
  • Speaking & faculty fees$1,5003%
  • Travel & lodging$17,88240%
  • Food & beverage$6,77215%
  • Education$1580%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurological surgery providers in Alaskato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$406,814
Medicare patients
201
Services billed
828

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam12$889
Gabapentin36$782
Minocycline Hcl21$361
Cyclobenzaprine Hcl44$348
Pregabalin15$138
Oxycodone Hcl17$127
Methocarbamol21$60

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →